Teva Pharmaceutical Industries Limited (TEVA)

Actavis Group • Actavis International Limited • Actavis U.K. Group Ltd. • Arrow International Limited • Mepha Schweiz AG • Merckle GmbH • Pliva Hrvatska d.o.o. • Ratiopharm GmbH • Salomon, Levin & Elstein Ltd. • Teva API B.V. ...

TEVA stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$21.50

Low target

$18.00

High target

$25.00

Latest filings (excl ownership)

View all

8-K

Departure of Directors or Certain Officers

6 Nov 24

Results of Operations and Financial Condition

31 Jul 24

Results of Operations and Financial Condition

31 Jul 24

8-K

Entry into a Material Definitive Agreement

25 Jun 24

8-K

Submission of Matters to a Vote of Security Holders

6 Jun 24

Conflict minerals disclosure

30 May 24

8-K

Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations

15 May 24

8-K

Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook

8 May 24

Transcripts

View all

TEVA

Earnings call transcript

2023 Q2

2 Aug 23

TEVA

Earnings call transcript

2023 Q1

10 May 23

TEVA

Earnings call transcript

2022 Q4

8 Feb 23

TEVA

Earnings call transcript

2022 Q2

27 Jul 22

TEVA

Earnings call transcript

2022 Q2

27 Jul 22

TEVA

Earnings call transcript

2022 Q1

3 May 22

TEVA

Earnings call transcript

2021 Q4

9 Feb 22

TEVA

Earnings call transcript

2021 Q3

27 Oct 21

TEVA

Earnings call transcript

2021 Q2

28 Jul 21

TEVA

Earnings call transcript

2021 Q1

28 Apr 21

Latest ownership filings

View all

144

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

Notice of proposed sale of securities

18 Jun 24

Financial summary

Financial statements Chart TEVA financial data

Quarter (USD)	Sep 24	Jun 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	3.32 bn	3.32 bn	3.32 bn	3.32 bn	3.32 bn	3.32 bn
Cash burn (monthly)	(no burn)	(no burn)	17.00 mm	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	n/a	47.37 mm	n/a	n/a	n/a
Cash remaining	n/a	n/a	3.27 bn	n/a	n/a	n/a
Runway (months of cash)	n/a	n/a	192.4	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

TEVA institutional ownership history Ownership history

54.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	526	427	+23.2%
Opened positions	129	130	-0.8%
Closed positions	30	58	-48.3%
Increased positions	165	121	+36.4%
Reduced positions	134	95	+41.1%

13F shares	Current	Prev Q	Change
Total value	8.54 tn	4.87 tn	+75.2%
Total shares	608.81 mm	424.97 mm	+43.3%
Total puts	4.72 mm	11.86 mm	-60.2%
Total calls	25.16 mm	14.26 mm	+76.4%
Total put/call ratio	0.2	0.8	-77.4%

Largest owners	Shares	Value	Change
BLK BlackRock	42.99 mm	$698.55 bn	-1.6%
FMR	41.98 mm	$682.15 bn	+97.6%
Ion Asset Management	36.33 mm	$590.36 bn	NEW
Clal Insurance Enterprises	32.34 mm	$525.67 mm	+12.3%
Migdal Insurance & Financial	29.12 mm	$473.17 mm	-2.5%
Menora Mivtachim	28.84 mm	$468.62 bn	+2.5%
Exor Investments	26.46 mm	$430.02 bn	+0.1%
PXGPE Phoenix	25.42 mm	$413.12 bn	NEW
Slate Path Capital	20.19 mm	$328.11 bn	-24.9%
STT State Street	17.72 mm	$287.99 bn	+9.2%

Largest transactions	Shares	Bought/sold	Change
Ion Asset Management	36.33 mm	+36.33 mm	NEW
PXGPE Phoenix	25.42 mm	+25.42 mm	NEW
FMR	41.98 mm	+20.73 mm	+97.6%
Millennium Management	12.13 mm	+12.13 mm	NEW
Glenview Capital Management	9.16 mm	+9.16 mm	NEW
PointState Capital	9.15 mm	+9.15 mm	NEW
MS Morgan Stanley	13.14 mm	+7.71 mm	+142.2%
Slate Path Capital	20.19 mm	-6.71 mm	-24.9%
D. E. Shaw & Co.	5.89 mm	+5.89 mm	NEW
BAC Bank of America	5.31 mm	+5.31 mm	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TEVA insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Dec 24	Chen Lichtenstein	Restricted Share Units Ordinary Shares	Grant	Acquire A	No	No	0	4,804	0.00	4,804
20 Nov 24	Christine Fox	Ordinary Shares	Sell	Dispose S	No	Yes	16.8705	19,388	327.09 k	44,104
20 Nov 24	Christine Fox	Ordinary Shares	Option exercise	Acquire M	No	No	0	63,492	0.00	63,492
20 Nov 24	Christine Fox	Restricted Share Units Ordinary Shares	Option exercise	Dispose M	No	No	0	63,492	0.00	190,476
2 Sep 24	Varda Shalev	Ordinary Shares	Option exercise	Acquire M	No	No	0	12,872	0.00	12,872
2 Sep 24	Varda Shalev	Restricted Share Units Ordinary Shares	Option exercise	Dispose M	No	No	0	12,872	0.00	0
18 Jun 24	Mignone Roberto	Ordinary Shares	Sell	Dispose S	Yes	No	17.03	519,000	8.84 mm	981,000